ReviewClinical, cosmetic and investigational dermatology2025
Artificial Intelligence and Large Language Models in the Fight Against Superficial Fungal Infections: Friend or Foe?
Review in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence in the Diagnosis of Superficial Mycoses: A Scoping Review.Journal of fungi (Basel, Switzerland) · 2026Review
- Formulation-Driven Innovation in Antifungal Therapy: From Nanotechnology to AI-Assisted Design.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superficial fungal infections can have significant physical and psychological consequences for affected patients. These painful infections have become more prevalent and the rise of antifungal resistant strains is of great concern. New tools in the fight against these infections are needed, especially in areas were appropriate dermatological care is lacking. Artificial intelligence (AI) offers a potential solution for these care gaps. AI's capabilities have been increasing in sophistication at an astonishing pace, with large language models (LLMs), such as ChatGPT (OpenAI), Claude (Anthropic) and Gemini (Google) being capable of generating detailed responses to complex problems as well as demonstrating reasoning type behaviour. AI is currently in use and being developed for use within the clinic as well as the laboratory, with the potential to significantly improve access to dermatological care and patient outcomes. However, understanding how these AI models work at a basic level is necessary for safe, effective and efficient use and application to the management of superficial fungal infections. In this review, we provide a high-level description of how these models work, discuss the potentials and pitfalls of AI and LLMs, as well as their applications and the current and future outlook for the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.